Molecular Targets in Alzheimer’s Disease: From Pathogenesis to Therapeutics
Alzheimer’s disease (AD) is characterized by progressive cognitive decline usually beginning with impairment in the ability to form recent memories. Nonavailability of definitive therapeutic strategy urges developing pharmacological targets based on cell signaling pathways. A great revival of intere...
Main Authors: | Xuan Cheng, Lu Zhang, Ya-Jun Lian |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/760758 |
Similar Items
-
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
by: Jun-Lin Liu, et al.
Published: (2018-09-01) -
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
by: Tiwari S, et al.
Published: (2019-07-01) -
Alzheimer's Disease Pathogenesis Core Concepts, Shifting Paradigms and Therapeutic Targets
Published: (2011) -
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
by: Tiantian Guo, et al.
Published: (2020-07-01) -
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
by: Hafza Wajeeha Ejaz, et al.
Published: (2020-10-01)